NEW YORK (GenomeWeb News) – Quest Diagnostics today said that it has launched a reorganization of the firm that includes the creation of two new business groups and the elimination of approximately 400 to 600 management positions.

The Madison, NJ-based clinical lab firm, which has steadily increased its presence in the molecular diagnostics field, said that it will eliminate its current business structures and replace them with two new business units: Diagnostic Information Services and Diagnostic Solutions. The change will become effective on Jan. 1, 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.